Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
Next >
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
September 25, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Science
From
CNBC.com News
5 things to know before the stock market opens Wednesday
September 25, 2024
Tags
Technology
Business
Markets
From
CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
Tags
Health & Science
GSK plc
Astellas Pharma Inc
From
CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
September 24, 2024
Tags
Companies
Health care industry
Health & Science
From
CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
September 23, 2024
Tags
OREILLY AUT DRN
Stock markets
Vistra Corp
From
CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
September 22, 2024
Tickers
NEWS
NVO
Tags
News
Zain Rizvi
Novo Nordisk A/S
From
Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
September 20, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
September 18, 2024
Tags
Novartis AG
Roche Holding AG
Health care industry
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Health & Science
Healthy Returns
Health care industry
From
CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
September 16, 2024
Tags
Technology
Inflation
Business
From
CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
September 12, 2024
Tickers
JOBS
Tags
Jobs
Bitcoin
Inflation
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Companies
Business
Pharmaceuticals
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Eli Lilly and Co
Novo Nordisk A/S
Social issues
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Health & Science
Healthy Returns
Abbott Laboratories
From
CNBC.com News
5 things to know before the stock market opens Tuesday
September 03, 2024
Tags
Technology
Business
Markets
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Europe News
Markets
Europe Markets
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
August 21, 2024
Tags
Breaking news
Companies
Business
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Eli Lilly and Co
US: News
Novo Nordisk A/S
From
CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
August 15, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Business News
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Health & Science
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Health & Science
Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Science
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Business
Health care industry
Breaking news
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Novo Nordisk A/S
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.